Cytokinetics CYTK
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–
CYTK Stock News
Headlines matching Cytokinetics or the CYTK ticker, most recent first.
- Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
- Cytokinetics(CYTK.US) Officer Sells US$7.34 Million in Common Stock
- Form 144 | Cytokinetics(CYTK.US) Insider Proposes to Sell 7.09 Million in Common Stocks
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
- RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
- A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140
- A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140
- BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85
- Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating
- Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110 Positive
- Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $103 Positive
- Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $102
No comments yet — be the first to weigh in on CYTK.
Sign in to join the discussion.